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Abstract
Background: The aim of this paper is to show how researchers balance between scientific rigour
and localisation in conducting pragmatic trial research. Our case is the Quattro Study, a pragmatic
trial on the effectiveness of multidisciplinary patient care teams used in primary health care centres
in deprived neighbourhoods of two major cities in the Netherlands for intensified secondary
prevention of cardiovascular diseases.
Methods: For this study an ethnographic design was used. We observed and interviewed the
researchers and the practice nurses. All gathered research documents, transcribed observations
and interviews were analysed thematically.
Results: Conducting a pragmatic trial is a continuous balancing act between meeting
methodological demands and implementing a complex intervention in routine primary health care.
As an effect, the research design had to be adjusted pragmatically several times and the intervention
that was meant to be tailor-made became a rather stringent procedure.
Conclusion: A pragmatic trial research is a dynamic process that, in order to be able to assess the
validity and reliability of any effects of interventions must also have a continuous process of
methodological and practical reflection. Ethnographic analysis, as we show, is therefore of
complementary value.
Background
The question has been raised to what extent evidence
from controlled clinical trials on prevention interventions
is of value in the routine clinical practice of primary care
[1-6]. Explanatory trials, the randomised controlled trials
(RCTs) measuring the treatments' efficacy, meet the crite-
ria for valid evaluation through randomisation, recruiting
a sufficiently large number of subjects and using control
situations [7-9] plus reliable measurements. Pragmatic tri-
als, as opposed to explanatory RCTs, measure the effec-
tiveness of treatments in routine clinical practice
[8,10,11]. In pragmatic trials, the definition of the treat-
ments is more or less standardised to correspond with
daily clinical decision-making. Additionally, the heteroge-
neity of patients is reflected, fewer exclusion criteria are
used, and blinding, randomisation and control situations
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als are preferable when health care provision and services
are to be evaluated, because their external validity to the
extent of their usefulness in routine clinical practice is not
compromised [12]. In the literature, pragmatic trials are
considered to provide a realistic alternative to conven-
tional RCTs [10,11,13,14].
The way that researchers actually deal with conducting
pragmatic trials remains largely unexplored. In fact, there
have been few publications examining the work that goes
into producing evaluative outcomes and managing prag-
matic trials or, for that matter, on RCTs (e.g.[15]). In this
paper we show how researchers balance between scientific
rigour and localisation in pragmatic trial research. Our
case is the Quattro Study, a pragmatic trial on the effec-
tiveness of multidisciplinary patient care teams used in
primary health care centres in deprived neighbourhoods
of two major cities in the Netherlands for intensified sec-
ondary prevention of cardiovascular diseases (CVD). To
increase the chance of implementation of this project, a
major condition was that the research interference with
daily care routines was kept to a minimum. As the project
adopted a 'tailor made approach', the GPs and the sup-
portive staff were asked to develop their own procedures
for the program, albeit within preset conditions, as only
they could develop guidelines that would fit into their
specific local situation. Our main question was: How do
researchers cope with the methodological dilemmas of
localising the execution of the trial in the participating pri-
mary health care centres?
Methods
We used an ethnographic design. By means of participant
observations [16-18], the first author observed the work
of two researchers, a data manager, and four research
assistants from April 2003 till December 2004. In this
period, we also observed 20 research progress meetings.
All meetings, observations and conversations were tran-
scribed. Minutes of the meetings, research protocols, doc-
uments and questionnaires used for the Quattro Study
were collected. From April 2003 until December 2004, the
first author observed four out of seven practice nurses in
their daily work, each for five workdays. Throughout each
observation, it was possible to ask questions or to request
clarification. Transcripts were made immediately after
leaving the health care centres. Audiotaped semi-struc-
tured interviews were held with the researchers, project
leader, data manager and three practice nurses up to Jan-
uary 2006. All interviews were transcribed immediately
after the interviews and were sent back to the interviewees
for member check.
After the observation period, all transcripts, minutes, and
research documents were analysed more in-depth. We
analysed all information manually and thematically,
establishing overarching categories.
Study setting
Aim of the Quattro-study was to examine the effectiveness
and cost-effectiveness of a multidisciplinary collaboration
between a practice nurse, a peer health educator, the GP,
and assistant in providing intensified preventive care in
general practices located in deprived neighbourhoods.
The Quattro Study was a randomised controlled trial
(RCT) carried out in three primary health care centres
located in the deprived neighbourhoods of Rotterdam
and The Hague. Patients in the intervention group
obtained Quattro-care and three-monthly assessments of
the risk profile. Patients from control group A received
usual GP care and three-monthly risk assessments and the
GP as well as the patient were informed about the results
of these measurements. It was thought to be ethically and
practically unacceptable to assess a risk profile and not to
inform the patient and GP about the results. However,
this approach of assessing risk and informing patients and
GP interferes with daily practice and may bias the results.
Therefore, a blinded control group B was needed to quan-
tify the effect of the risk assessments. This group received
usual GP care and was measured once at the end of the
study.
The follow-up period for the intervention and control
group A was 12 months and the intervention programme
lasted 9 months. Participants in the study were patients at
high risk of developing CVD; i.e. patients with a modifia-
ble part of the absolute 10-year risk equal or greater than
5% contributed by smoking, hypertension or hypercho-
lesterolemia.
The intervention consisted of the formation of a primary
care team in the general practice composed of the GP,
assistant, practice nurse and peer health educator (Quat-
tro-care). The intervention protocol was based on GP
guidelines for hypertension, hypercholesterolemia, diabe-
tes mellitus, smoking and obesity, and described the pro-
cedures for the intervention team (GP (treatment task),
practice nurse (risk assessment, coordination and inform-
ative task), assistant (logistic task) and peer health educa-
tor (ethnic specific health education)). Although the main
lines of the protocol were fixed for participating general
practices (e.g. 4 structured team meetings of the Quattro-
care team and 4 individual education sessions), the proto-
col allowed adapting to tailor the intervention to the indi-
vidual practice needs and organisation.
The effectiveness of the multidisciplinary collaboration
was assessed by comparing patients from the intervention
group with those from control group A after one year fol-Page 2 of 6
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lute 10-year risk of developing CVD.
Control group B, aimed to quantify the effect of structured
risk assessments performed in control group A, was com-
pared with control group A.
The study ran from August 2000 until December 2005.
Complementary qualitative research was considered nec-
essary during the execution of the trial to evaluate feasibil-
ity, implementation and experiences with Quattro-care of
health care professionals, patients and researchers. Ethical
approval for the Quattro Study, which also incorporated
the complementary qualitative research, was obtained
from the Health Ethics Board of Erasmus University Med-
ical Center in Rotterdam.
Results
Pragmatic decisions
Patient recruitment was a major concern in the Quattro
Study. The researchers had to adapt the inclusion proce-
dure to overcome a too homogeneous composition in,
and a shortage of, eligible patients. The research team
decided to change the age parameters from 18–70 years of
age to 30–70 years of age in order to ensure a more repre-
sentable proportion of the target population (document
selection criteria addendum 2). Changing the age param-
eters in a study performed in deprived neighbourhoods
would prevent a possible over-representation of indige-
nous male patients with a high absolute risk of CVD, with
little or no elevated cardiovascular risk factors (document
selection criteria addendum 2). Focusing on the absolute
10-year risk alone for both male and female patients
would result in excluding a large number of eligible, rela-
tively young, predominantly female patients [19]. The
inclusion of sufficient numbers of women, ethnic groups
and the prevention of a possible over-representation of
white males became important issues next to the risk of
CVD. The adjustment of inclusion criteria enabled a more
accurate representation of the patient population of the
participating health care centres in the intervention.
The participating GPs were able to decide whether
patients had to be protected from the stress of participa-
tion because of a too complex medical history (severe co-
morbidity). The GPs vetoed 641 patients (document final
report). The reasons for rejection were 'the patient being
under care of a specialist', 'the patient being correctly
monitored' or 'other reason:...' (document patient risk
profile form). This elimination of patients proved to be a
disproportionate part of the eligible group of patients and
adopting the GP vetoes would result in a too small target
population needed for the study. Besides, the amount of
vetoed patients was unevenly distributed among the par-
ticipating GPs, making future comparison and extrapola-
tion of found effects difficult. To enable the intervention
to represent routine medical decision-making the research
team chose to review the vetoed patients and readmitted
43 patients. Eventually, from the selected 2,263 eligible
patients between 30–70 years old and with at least one
CVD risk factor, the researchers were able to include 1,665
eligible patients into the study (document final report).
Pragmatic approach and systematic design
For the researchers, blinding patients and preventing con-
tamination between intervention and control group A
patients were major concerns for establishing the effec-
tiveness of the study. Blinding patients for the health care
professional, however, proved to be problematic. The
problems started to develop as soon as the patients arrived
at the centres for their appointments. For the assistants at
the reception desks it was unclear to which group a partic-
ular patient belonged and 'mistakes' in the allocation of
patients were made. Control group A patients were either
seen as intervention group patients when they were not,
or were referred back to the researchers without receiving
Quattro care (field notes research progress meeting 10-09-
2003 and 23-03-2004).
The research team decided to provide the health care cen-
tres with a list of names of the patients included in inter-
vention and control group A. This point received an
additional remark in the minutes: "Methodologically not
really correct, but a concession" (minutes research
progress meeting 10-09-2003). As the researchers pro-
vided name lists to the health care centres, the researchers
endangered the internal validity of the project as they
informed the health care centres about which patients
belonged to which research group. In the study design the
possibility of contamination was already incorporated, as
the centres were responsible for the internal organisation
of the intervention and adjusting the intervention to the
local circumstances (document research proposal). The
trial was, therefore, not badly designed; the research team
was merely forced to make it workable for the centres.
From a pragmatic to a systematic intervention
For the researchers the assessment of the effectiveness of
the multidisciplinary care teams was the core of the whole
project. They planned the individual patient education
sessions given by the practice nurse and/or migrant health
educator. Multidisciplinary team meetings attended by all
four professionals were to follow each other continuously
within the centres (document manual for intervention
2000). This part of the project differed between the care
practices, as multidisciplinary team meetings were either
organised (but irregular and without all health care pro-
fessionals attending), limited to only practice nurses and
GPs, or informal deliberations. Because all health centres
appropriated the intervention towards their own local cir-Page 3 of 6
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each centre.
The adjustments in the centres endangered the establish-
ment of the ultimate effect of the project and were seen as
"seriously inconvenient for the study. This way, the trial
becomes impure." (field note research progress meeting
11-05-2004). As a result, the research team increased its
interference in the intervention by having the multidisci-
plinary team meetings stringently implemented for estab-
lishing the effect of the structural collaborative care
opposed to regular care on the reduction of CVD risk less
ambiguously. " [...] if we make too many concessions the
results will drift away from the original idea, meaning we
cannot say anything about the whole project at the end"
(conversation researcher 01-06-2004). The team eventu-
ally developed a Quattro guideline for the health care cen-
tres to work with and organised regular supportive
intervention progress meetings for the practice nurses and
peer health educators.
The project leader, however, constantly tried to prevent
research interference within the health care centres from
happening because, for him, these differences in practice
were not a problem but important for gaining insight into
what kind of organisational preconditions primary health
care must meet if the implementation of prevention
projects is to be successful (conversation project leader
10-09-2003). "To be able to say anything about the effects
of such a prevention project in real life practice, the trial
has to have as little contact with the actual intervention as
possible" (conversation project leader 10-09-2003).
From a pragmatic to a systematic follow-up
For establishing the effectiveness of the project, the
researchers needed to be informed by the professionals
about the data from the follow-up. The needed data were
the physical measurements of patients, like BMI, blood
pressure, total cholesterol, and fasting capillary glucose
levels (or HbA1c). Moreover, they also needed data to
measure the (costs of the) intervention, such as time spent
by all professionals on the specific parts of this project, i.e.
intake, patient consultations, and multidisciplinary meet-
ings (document research proposal).
Getting the professionals to register and deliver the data,
however, proved to be problematic (minutes research
progress meeting 20-01-2004). As a result the researchers
took measures concerning the data collection. First, the
research team decided that the forms used by the health
care professionals should contain fixed data, so that the
researchers could use these forms too (minutes research
progress meeting 20-01-2004). They also decided " [...]
the research assistants would have to resolve the lacunas
in the research data" (field note research progress meeting
03-02-2004). However, some lacunas in data could not be
resolved. Data was either not recorded, and thus the
research assistants had to retrieve these missing data from
the health care centres, or patients had not gone for their
lab measurements, resulting in data not being retrievable
at all.
The follow-up of patients in this way increasingly became
important as measuring point to establish the effective-
ness of the trial, underscoring the systematic nature of the
data collection. As the promise of tailoring the interven-
tion resulted in the professionals appropriating the fol-
low-up procedures, informing the researchers about the
meantime follow-up results was seen to be an interference
with the daily routines. The researchers, however, had to
increase their efforts to collect the meantime follow-up
results in order to be able to establish the effectiveness of
the intervention systematically, as missing data in trials
entails a validity problem for analysing the ultimate esti-
mate of effect. The question to what extent the opportu-
nity of tailoring the intervention and its execution to the
local circumstances of the health care centres would result
in appropriations in data collection was, however, not
addressed.
Discussion
Executing a pragmatic trial is a continuous balancing act
for the researchers. Researchers constantly balance
between meeting methodological demands to produce a
scientifically rigorous effectiveness study and applying a
pragmatic approach to making feasible and implementing
a preventive intervention in primary health care. Both sys-
tematic and pragmatic approaches proved to be difficult
to retain. By means of ethnographic analysis, we showed
that the researchers conducting the Quattro Study had to
adjust the research to enable the intervention's uptake in
routine primary care. The researchers adapted the inclu-
sion procedure to overcome the homogeneous composi-
tion of, and a shortage in, eligible patients and provided
the health care professionals the name lists of included
patients in order to restrict the provision of care to
research groups. Moreover, the researchers had to increase
their interference in the pragmatic execution of the inter-
vention to have the trial performed more systematically.
The researchers increased their interference in the organi-
sation of the intervention by having the multidisciplinary
team meetings implemented stringently and by having
the data collected as systematically as possible. Our con-
tention is that this balancing act is not a feature of this spe-
cific trial, nor that it points at methodological weaknesses,
but a structural dilemma for pragmatic trials.
Pragmatic trials, we showed in this paper, pose substantial
challenges to investigators. Such trials hold the premise of
being both 'pragmatic' (enabling the uptake of treatmentsPage 4 of 6
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ing and incorporating the heterogeneity of patients and
health care professionals) and 'systematic' (establishing
the effectiveness of treatments by means of a scientific
method of experimental design and predefined outcome
measures). The constant interaction between research and
primary care leads to continuous adjustments in research
and intervention. Reconciling the tensions between the
two different intellectual traditions, as indicated by
Campbell et al [20] and illuminated by Marks [21] make
the pragmatic and the systematic parts of pragmatic trials
influence each other in opposite directions.
As pragmatic trial research is a dynamic process in which
the parts of research and (health care) practice will be
redefined repeatedly, a continuous process of methodo-
logical and practical reflection is imperative. Otherwise,
pragmatic trials may end up in being just a contradiction
in terms. So, we do not suggest to solely focus on practical
research strategies for improving study design, trial execu-
tion and generalisability of results as advocated by Camp-
bell et al. [20] and Ward [22]. Neither do we suggest to
focus the research efforts solely on the development of
meaningful evidence about routine care, as is suggested by
MacPherson [9]. Stead, we suggest using qualitative (eth-
nographic) analyses to evaluate the continuous interfer-
ence of research and care in pragmatic trials, especially to
be able to assess the validity and reliability of any effects
of interventions (see e.g. [23,24]). Such analyses, as we
experienced with the Quattro case, help the researchers in
both finding and accommodating diversions between the
pragmatic and systematic aspects of pragmatic trial
research.
We therefore consider the information acquired by quali-
tative research important in both formative [23] and proc-
ess evaluations [23] of pragmatic trial projects. As we were
able to provide the researchers with ethnographic infor-
mation concerning, for example, the differences in organ-
ising the multidisciplinary team meetings and the follow-
up procedures among and within the health care centres,
we provided an additional reflexive dimension for mak-
ing adjustments in both research and practice. In addi-
tion, ethnographic process evaluations explicate the
sequence of actions [25] performed in pragmatic trial
projects. Qualitative research not only provides reflection
on the inevitability of adjustments in pragmatic trials, it
also provides reflection on the consequences of these
adjustments.
Our ethnographic analysis itself of course also does have
certain limitations. One is that our process evaluation on
conducting a pragmatic trial may be biased due to the fact
we only observed one pragmatic trial case. Because we did
not observe other researchers conducting other pragmatic
trials, we are aware that our accounts may not be general-
isable in all respects. However, we do argue that balancing
pragmatism and systematisation are structural to all prag-
matic trials, although this may take different forms in
other pragmatic trials. Secondly, our accounts may also be
biased due to the fact that systematic ethnographic obser-
vations in the Quattro Study only started when the imple-
mentation was already taking place. All information
about the project prior to those observations came out of
the project's archive and on the basis of interviews and
may thus be subjected to out-of-context interpretations.
However, we have tried to triangulate all data as much as
possible to overcome these biases.
Conclusion
Pragmatic trials on complex interventions in primary
health care pose substantial challenges to investigators. As
we have shown, pragmatic trial research consists of con-
stant interaction between research and health care prac-
tices; this leads to adjustments in research with respect to
what part of the study should be systematically performed
and executed to answer to scientific demands and what
part of the project could have a pragmatic set-up in the
health care centres. In the practice of pragmatic trial
research, parts of research and health care practice will be
redefined over and over again. Because pragmatic trial
research is a dynamic process, in order to be able to assess
the validity and reliability of any effects of interventions,
it must also have a continuous process of methodological
and practical reflection. Ethnographic analysis, as we
showed, is therefore of complementary value.
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